Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 4 A, Sup. Fig. 2 A
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 B, Sup. Fig. 2 A D
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 C, Sup. Fig. 2 A C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 D, Sup. Fig. 2 A C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 E, Sup. Fig. 2 B
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 F, Sup. Fig. 2 B
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 G, Sup. Fig. 2 C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 H, Sup. Fig. 2 C D
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 I, Sup. Fig. 2 C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 4 J, Sup. Fig. 2 A D
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|